ProfileGDS4718 / 226002_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 72% 79% 77% 82% 67% 61% 76% 82% 82% 80% 73% 59% 66% 68% 79% 83% 62% 58% 51% 77% 78% 81% 81% 77% 64% 76% 65% 80% 66% 62% 64% 68% 83% 53% 63% 69% 70% 78% 80% 81% 59% 65% 63% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.2859775
GSM549102patient 115, normal, homogenized [OPG study]7.0031972
GSM549104patient 119, normal, homogenized [OPG study]7.809679
GSM549108patient 138, normal, homogenized [OPG study]7.4749477
GSM549119patient 077, normal, homogenized [OPG study]8.0161582
GSM549133patient 032, cancer, homogenized [OPG study]6.6799267
GSM549139patient 042, cancer, homogenized [OPG study]6.1872861
GSM549099patient 107, normal, homogenized [OPG study]7.3628876
GSM549109patient 139, normal, homogenized [OPG study]8.0761982
GSM549110patient 046, normal, homogenized [OPG study]8.0704582
GSM549114patient 063, normal, homogenized [OPG study]7.9401680
GSM549122patient 082, normal, homogenized [OPG study]7.1227873
GSM549134patient 033, cancer, homogenized [OPG study]6.0528559
GSM549136patient 036, cancer, homogenized [OPG study]6.5659666
GSM549140patient 044, cancer, homogenized [OPG study]6.7388768
GSM549111patient 047, normal, homogenized [OPG study]7.8321279
GSM549113patient 057, normal, homogenized [OPG study]8.2906383
GSM549132patient 031, cancer, homogenized [OPG study]6.2907762
GSM549137patient 038, cancer, homogenized [OPG study]6.0184358
GSM549142patient 047, cancer, homogenized [OPG study]5.6810651
GSM549100patient 110, normal, homogenized [OPG study]7.4274977
GSM549107patient 135, normal, homogenized [OPG study]7.6415178
GSM549115patient 068, normal, homogenized [OPG study]8.0533581
GSM549116patient 072, normal, homogenized [OPG study]7.9965981
GSM549120patient 078, normal, homogenized [OPG study]7.5566177
GSM549131patient 030, cancer, homogenized [OPG study]6.4396964
GSM549118patient 074, normal, homogenized [OPG study]7.4238976
GSM549129patient 027, cancer, homogenized [OPG study]6.5231465
GSM549123patient 088, normal, homogenized [OPG study]7.8983280
GSM549124patient 006, cancer, homogenized [OPG study]6.529566
GSM549126patient 015, cancer, homogenized [OPG study]6.244262
GSM549128patient 025, cancer, homogenized [OPG study]6.4402664
GSM549103patient 117, normal, homogenized [OPG study]6.6782268
GSM549117patient 073, normal, homogenized [OPG study]8.2648883
GSM549138patient 041, cancer, homogenized [OPG study]5.7118153
GSM549141patient 045, cancer, homogenized [OPG study]6.3352163
GSM549130patient 028, cancer, homogenized [OPG study]6.7337569
GSM549101patient 111, normal, homogenized [OPG study]6.9093470
GSM549105patient 128, normal, homogenized [OPG study]7.6025978
GSM549106patient 134, normal, homogenized [OPG study]7.9829780
GSM549112patient 048, normal, homogenized [OPG study]7.9794981
GSM549125patient 011, cancer, homogenized [OPG study]6.0876559
GSM549127patient 024, cancer, homogenized [OPG study]6.5593865
GSM549135patient 035, cancer, homogenized [OPG study]6.3131363